Cataract
Conditions
Brief summary
Congenital cataract is an important treatable cause of visual handicap in childhood throughout the world. Successful management of childhood cataract is dependent on individualized treatment strategies and rigorous postoperative supervision for adverse complication. In this trial, we aimed to compare the difference of postoperative outcome between surgical timing at age of 3 month and 6 month. Patients enrolled into the study will be followed for two year and will have study visits at 1 day, 1 week, 1 month, 3 month, 6 month, 9 month, 12 month, 18month and 24month postoperatively.
Detailed description
Congenital cataract is a priority of Vision 2020: the Right to Sight, the global initiative to reduce the world's burden of avoidable blindness, because it is an important treatable cause of visual handicap in childhood throughout the world. Successful management of childhood cataract is dependent on individualized treatment strategies and postoperative supervision for adverse complication is also essential. The timing of surgery of childhood cataract depends on the etiology and on the degree of visual interference. Severe bilateral cataracts with significant obstruction of the visual axis must be treated and surgery is recommended as soon as possible after discovery. Several previous studies claimed that ideally cataracts should be removed before 3 months of age, while the result of recent researches shows that too early intervention for cataract surgery seems aggressive and would cause serious complications, which might cause poor long-term visual outcomes. Therefore, in order to control childhood blindness and severe visual impairment in China, it is of great importance to ensure that pediatric patients with cataract could have good timing of surgery, postoperative rigorous supervision, accurate optical rehabilitation and comprehensive treatment of amblyopia. In this trial, we aimed to compare the difference of postoperative outcome between surgical timing at age of 3 month and 6 month. Patients enrolled into the study will be followed for two year and will have study visits at 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months, 18months and 24months after cataract surgery.
Interventions
The surgical timing of phacoemulsification is perform at the age of 3 month of the patients. During Phacoemulsification, viscoelastic materials and anterior lens capsule are used to protect corneal endothelial cells.
The surgical timing of phacoemulsification is perform at the age of 6 month of the patients. During Phacoemulsification, viscoelastic materials and anterior lens capsule are used to protect corneal endothelial cells.
All patients received subconjunctival dexamethasone (2 mg) during surgery, and all surgeries were performed under general anesthesia.
Sponsors
Study design
Eligibility
Inclusion criteria
* Children diagnosis with bilateral congenital cataract for entire lens without other ocular abnormality * No more than 3 month old * Have signed a consent form * Can be followed
Exclusion criteria
* Children not identified with congenital cataract * Have not signed consent form * Be not able to be followed
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from baseline in the central subfield thickness (CST) measured by Optical Coherence Tomography(OCT) | during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month |
| Change from baseline in the thickness of the inner retinal layer regions measured by Optical Coherence Tomography(OCT) | during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month |
| Change from baseline in the thickness of the outer retinal layer regions measured by Optical Coherence Tomography(OCT) | during surgery,postoperation time:1day,1week,1month,3month,6month,9month,12month,18month,24month |
Secondary
| Measure | Time frame |
|---|---|
| Number of participants with abnormal intraocular pressure or diagnosis with secondary glaucoma | 2 year after surgery |
| Number of participants undergoing Nd:YAG laser capsulotomy due to severe posterior capsular opacification(PCO) | 2 year after surgery |
Countries
China